GRADE & PURITYMoligand™?Moligand™ — Aladdin's line of ligands and bioactive small molecules. Use for receptor, pathway, and binding studies needing defined small-molecule tools.
This compound belongs to the class of organic compounds known as phenyltetrazoles and derivatives. These are compounds containing a phenyltetrazole skeleton, which consists of a tetrazole bound to a phenyl group.
External Descriptors
Not available
1. Djoumbou Feunang Y, Eisner R, Knox C, Chepelev L, Hastings J, Owen G, Fahy E, Steinbeck C, Subramanian S, Bolton E, Greiner R, and Wishart DS. ClassyFire: Automated Chemical Classification With A Comprehensive, Computable Taxonomy. Journal of Cheminformatics, 2016, 8:61.
Determine the necessary mass, volume, or concentration for preparing a solution.
Dilution Calculator
Determine the dilution needed to prepare a stock solution.
Reconstitution Calculator
Revisões
Avaliações dos Clientes
Application Protocols
No tested application protocols are provided in the Product Data for AZ12971554.
Item-specific details
Recommended dilutions, platforms (e.g., WB, IHC, IF, FC), or positive controls: Not specified for this item.
General guidance for small-molecule screening (non-clinical)
Prepare a 10 mM DMSO stock; perform serial dilutions (e.g., 1:3) to generate a concentration–response curve. Keep final DMSO constant (≤0.1–1% v/v) across wells.
Include vehicle controls, assay interference controls, and, if available, a known active comparator.
Record lot number and preparation details in your ELN to ensure reproducibility.
Refer to your internal SOPs for platform-specific parameters and acceptance criteria.
Biological Roles
Item-specific biological information
Known targets, pathways, or modes of action: Not specified for this item; refer to CoA/Spec Sheet or primary literature associated with the CID if available.
General context for coded library compounds (non-clinical)
Compounds in discovery libraries may span diverse chemotypes with potential to modulate enzymes, receptors, transporters, or protein–protein interactions. Absent disclosed structure or prior art, any biological role is exploratory and must be established empirically.
Early assessments typically include biochemical potency, cell permeability, metabolic stability (microsomes/hepatocytes), and basic ADME proxies such as solubility and logD (assay-dependent, not provided here).
Practical notes
Mitigate artifacts: control for fluorescence/absorbance overlap, redox activity, and colloidal aggregation that can masquerade as biological effects.
If a preliminary activity is observed, verify dose–response reproducibility, time dependence, and reversibility; evaluate selectivity across related targets to understand chemotype behavior.
This product is provided strictly for research use; no nutritional or therapeutic role is claimed or implied.
Buffer Applications
This item is not a buffer reagent. However, practical handling in buffered systems is common for screening experiments.
General guidance for assay buffers (not item-specific)
Choose buffers with minimal analyte interaction (e.g., HEPES, PBS, Tris) at appropriate ionic strength. Maintain DMSO at ≤0.1–1% v/v final, consistent across all wells/samples.
For pH-sensitive readouts, pre-equilibrate compound dilutions in buffer to avoid transient pH shifts. If the compound contains ionizable groups (unknown here), pH can strongly impact solubility and potency.
Add a small amount of nonionic detergent (e.g., 0.01–0.05% Tween-20) to reduce nonspecific adsorption and aggregation where compatible.
Operational tips
Prepare a concentrated DMSO stock (e.g., 10 mM), then serially dilute into buffer to the desired working concentration, keeping final DMSO constant.
Inspect for precipitation or turbidity after dilution; if observed, increase dilution steps, adjust buffer composition, or add co-solvent within assay limits.
Refer to your assay SOPs for specific buffer recipes and acceptance criteria.
Green Alternatives
In the absence of structural details, green considerations focus on solvent and process choices during handling, analysis, or potential derivatization.
Greener solvent substitutions (general)
Replace chlorinated solvents in workup/analysis with ethyl acetate, isopropanol, or acetonitrile where performance allows.
For synthetic steps (if pursued post-structure disclosure), consider 2-MeTHF or CPME instead of THF/Et2O for extractions or moisture-sensitive operations.
For stock solutions, DMSO remains a standard; truly green aqueous vehicles can be explored only if the compound is sufficiently water-soluble. Co-solvent options include propylene glycol or PEG-400 at low percentages for certain bioassays (assay-dependent).
Small comparison (general)
THF vs 2-MeTHF: Similar utility; 2-MeTHF offers better renewability and phase-splitting but may alter reaction rates.
DCM vs EtOAc: EtOAc is biodegradable and less problematic; polarity profile differs.
DMF/DMSO vs Cyrene: Cyrene is bio-based; limited compatibility window and different solvency profile.
Process intensification
Miniaturize assays (low volumes, high-density plates) to reduce solvent and waste.
Use LC methods with shorter columns and water-rich gradients to cut organic usage, when analyte UV/ionization permits.
Adopt greener choices case-by-case, verifying analytical and biological compatibility before substitution.
Pharmaceutical Uses
No pharmacopeial or excipient status is provided for this item, and it is sold strictly for research use only.
Item-specific status
Regulatory/compendial listings: Not specified for this item.
Intended role: Research compound for discovery and screening; not for human or veterinary use.
General considerations (non-clinical)
In early discovery, coded compounds may be used for pre-formulation screening to understand solubility limits, stability in simulated fluids, and compatibility with common vehicles—these data are project-specific and not provided here.
Any transition toward development-grade materials requires fully disclosed structure, impurity profiles, and materials manufactured under appropriate quality systems. This listing does not imply suitability for clinical or diagnostic applications.
Always consult internal quality/regulatory teams before using any discovery compound beyond basic research.
Physical Properties
Item-specific values are not listed in the Product Data. Do not treat any numbers below as specifications for this catalog entry.
Item-specific (from Product Data)
Appearance: Not specified for this item; refer to CoA/Spec Sheet.
Melting point / Boiling point: Not specified for this item; refer to CoA/Spec Sheet.
Density / Refractive index: Not specified for this item; refer to CoA/Spec Sheet.
Solubility: Not specified for this item; refer to CoA/Spec Sheet.
LogP, pKa: Not specified for this item; refer to CoA/Spec Sheet.
Literature/general expectations for coded screening compounds (non-specific guidance)
Physical form: Often supplied as solids or films for DMSO stock preparation; hygroscopicity varies by scaffold.
Solubility handling: Dimethyl sulfoxide (DMSO) is the most common solvent for 10–50 mM stocks; co-solvents such as DMF or ethanol may assist if solubility is limited (general practice).
Stability: Many discovery compounds are stable at room temperature when dry, but hydrolysis/oxidation sensitivity depends on functional groups (e.g., esters, aldehydes, anilines). Protect from moisture and prolonged light as a precaution when identity is unknown.
Always verify lot-specific physical constants and analytical purity on the CoA/Spec Sheet before quantitative use or formulation.
Quality and Grades
Item-specific grade (from Product Data)
Grade/Purity: Moligand™
What Moligand™ indicates (general explanation)
Moligand™ denotes a discovery/screening-grade small molecule suitable for hit identification, target interrogation, and SAR exploration. Lots are typically supported by orthogonal identity checks (e.g., LC–MS, 1H NMR) and mass purity assessments appropriate for screening workflows. Exact test suite, acceptance criteria, and any stabilizers are lot-dependent.
Practical implications for users
Analytical confirmation: For quantitative assays or as a reference standard, confirm identity/purity with the supplied CoA/Spec Sheet and consider in-house verification (LC–MS, qNMR) as needed.
Chromatography and detection: If using in HPLC/UPLC method development, be aware that UV profiles and extinction coefficients are structure-dependent and are not provided here.
Trace impurity data: Water content, residual solvents, inorganic residues, and metal content are not specified for this item; refer to CoA/Spec Sheet.
Stabilizers/additives: Not specified for this item; refer to CoA/Spec Sheet. If present, note downstream compatibility (bioassays, MS).
Selecting grade vs application
Screening/assay development: Moligand™ is appropriate.
Regulated or quantitative reference use: Evaluate whether additional purification or a higher documentation level is required for your workflow.
Reaction and Applications
Manufacturer Applications (from Product Data)
Specific application notes: Not provided for this item.
Discovery and screening use-cases (general, non-clinical)
Primary/secondary screening: Evaluate as one member of a small-molecule library against biochemical or cell-based assays. Maintain constant vehicle controls and perform serial dilutions (e.g., 10-point, 3-fold) for potency curves.
Target deconvolution & chemotype triage: If activity observed, confirm by orthogonal readouts to rule out assay interference (autofluorescence, redox cycling, aggregation). Employ counter-screens and detergent controls.
Analytical characterization: Validate identity/purity by LC–MS and, if needed, qNMR before mechanistic studies. Monitor stability in assay media (t1/2 in buffer/serum, general practice).
Practical tips
Control DMSO at a fixed final percentage across all wells/tubes.
Test for colloidal aggregation using low Triton X-100/Tween-20 controls (0.01–0.05%) and dynamic light scattering where appropriate.
Verify lack of pan-assay interference behavior (PAINS) via orthogonal assays and spectroscopic controls.
For photolabile scaffolds (unknown here), reduce light exposure during preparation and storage.
Synthetic chemistry angle
Without structural disclosure, no specific named reactions can be recommended. If derivatization is intended, obtain full structure and functional group map from CoA/IP sources before route design.
Reaction Conditions
No reaction conditions can be item-specifically recommended without a disclosed structure.
General guidance (if derivatization is contemplated after structure disclosure)
Choose solvents and temperatures aligned with the compound’s functional groups (e.g., base-sensitive motifs avoid strong alkoxide bases; oxidation-prone anilines avoid harsh oxidants).
Start with micro-scale scouting reactions and analytical monitoring (TLC/LC–MS). Map stability versus pH, heat, and light prior to scale-up.
Typical condition envelopes for library-like molecules (illustrative, not specific to this item): room temperature to 80 °C; reaction times from 0.5–16 h; catalysts/additives selected per transformation class (amide couplings, Suzuki–Miyaura, SNAr, etc.). All are contingent on functional groups which are not provided here.
Consult the CoA/Spec Sheet or internal structural dossier before attempting any chemical transformation.
Safety and Handling
Authoritative safety data are provided in the SDS. The Product Data list no GHS elements; handle as potentially hazardous by default.
Item-specific hazard info (from Product Data)
Signal word / H-statements / GHS classification / pictograms: Not specified for this item; refer to SDS.
General laboratory precautions for unknown small molecules
PPE: Safety glasses, lab coat, and appropriate chemically resistant gloves (e.g., nitrile). Use in a fume hood to avoid inhalation of dusts/aerosols.
Avoid: Skin/eye contact, inhalation, ingestion. Prevent exposure to incompatible oxidants/reductants until structure is confirmed.
First aid (overview; defer to SDS): Inhalation—move to fresh air; Skin—wash with soap/water; Eyes—rinse with water for several minutes; Ingestion—rinse mouth. Seek medical attention in all exposure cases.
Fire response: Treat as an organic combustible unless known otherwise. Use CO2, dry chemical, or foam. Avoid high heat that can cause decomposition and unknown toxic fumes.
Spill response: Contain, avoid dust generation, collect with inert absorbent, dispose according to local regulations.
Storage incompatibilities (general)
Until functional groups are known, avoid strong oxidizers, strong acids/bases, and reactive metals. Segregate from foodstuffs and incompatible chemicals. Label clearly as “For research use only.”
Solvent Selection
With no structure disclosed, solvent choice should follow best practices for coded screening compounds.
Primary stock solvent (general practice)
DMSO: First-line for 10–50 mM stocks. Broad solubilizing power; compatible with most biochemical assays at ≤0.1–1% v/v final.
Co-solvents and alternatives (general)
DMF: Useful for difficult scaffolds; monitor assay compatibility and cytotoxicity at low final %.
Ethanol/Isopropanol: Volatile, miscible with water; limit to ≤0.5–1% v/v in biological assays.
Acetonitrile: Good for analytical injections; limited use as biological vehicle.
Aqueous buffers: Only if compound is sufficiently water-soluble; consider pH adjustment if ionizable groups are present (unknown here).
Practical guidance
Start with 10 mM DMSO stock; verify complete dissolution visually and by LC if critical.
Filter 0.22 µm for sensitive assays if precipitation risk exists.
Keep final organic co-solvent content consistent across controls and test wells.
Comparison (general considerations)
DMSO: Highest solvating power; potential enzyme inhibition at high %.
Ethanol: Rapid evaporation; good for short handling.
DMF: Strong solvent; consider toxicity and material compatibility.
Always confirm solvent compatibility with your particular assay or synthetic step before scale-up.
Storage and Reconstitution
Item-specific storage (from Product Data)
Storage Conditions: Room temperature.
Shipped In: Not specified for this item; refer to CoA/Spec Sheet.
General storage guidance for coded small molecules
Keep container tightly closed in a dry, well-ventilated place. Minimize exposure to moisture, heat, and direct light until stability data are known. Consider desiccation for hygroscopic materials.
For long-term screening use, prepare aliquots to avoid repeated freeze–thaw or prolonged cap-open times that can concentrate or degrade stocks.
Reconstitution (general practice; not item-specific)
Prepare a concentrated DMSO stock (e.g., 10–50 mM) after confirming complete dissolution. If necessary, use sonication or gentle warming (<40 °C) to aid solubility, avoiding decomposition.
Filter (0.22 µm PTFE) if particles persist and the downstream assay tolerates filtration.
For aqueous working solutions, dilute the DMSO stock into buffer with thorough mixing; inspect for precipitation. Keep final DMSO percentage consistent across samples.
Always consult the lot-specific CoA/Spec Sheet and SDS for authoritative instructions on storage, stability, and handling.
Structure and Identity
Brief overview: AZ12971554 is a coded small-molecule research compound offered in Aladdin’s Moligand™ collection for screening and discovery workflows. Structural details are not disclosed in the listing.
Item-specific identifiers (from Product Data)
Product Name: AZ12971554 (SKU: A607832)
CAS: A607832 (catalog reference; registry-style number not verified)
CID: 44537923
InChIKey: 105862
SMILES: Not specified for this item; refer to CoA/Spec Sheet.
Molecular Formula: Not specified for this item; refer to CoA/Spec Sheet.
Molecular Weight: Not specified for this item; refer to CoA/Spec Sheet.
Structural features
2D/3D structure: Not provided in Product Data. Without SMILES or InChI, specific functional groups, ring systems, or stereochemical elements cannot be enumerated for this item.
Interpretation notes (general)
“AZ12971554” appears to be a discovery code designator. For cheminformatics, use the provided CID if available in public databases; otherwise, consult the lot-specific CoA for structural confirmation, exact synonyms, and analytical identifiers (e.g., LC–MS, 1H NMR).
Synthetic Utility
Because no structure or functional groups are disclosed in the Product Data, specific synthetic transformations cannot be prescribed for AZ12971554.
Potential roles (general)
Reference standard: Serve as an analytical comparator in method development (HPLC/UPLC-MS) once identity/purity are verified by CoA and in-house testing.
SAR probe: If the structure becomes available, analog generation can be planned to explore potency/selectivity trends; at this stage, derivatization strategies depend on accessible functional handles (unknown here).
Assay interference control: Use as a control in screening campaigns if historical behavior is known internally (not provided here).
Practical notes
Prior to any synthetic manipulation, obtain structural information and an impurity map. Without these, reaction planning (e.g., cross-coupling, amide formation, heterocycle modification) is speculative and not recommended.
If re-purification is needed for analytical grade work, select orthogonal methods (recrystallization vs. preparative HPLC) based on observed solubility and chromatographic behavior established experimentally.
Target Specificity
Item-specific target data
Target(s), pathway, or selectivity panel: Not specified for this item; refer to CoA/Spec Sheet or internal screening data.
General note
For coded screening molecules, target specificity must be established empirically through comparative assays, selectivity counterscreens, and profiling panels. No claims of specificity are made for this product listing.
Need help choosing the grade?
Our grade selection guide covers purity, stabilizer status, and application suitability for all variants in our catalog.
We use cookies to ensure the website functions properly and, where permitted, to improve your experience. You can manage your preferences at any time in Settings. Learn more in our Cookie Policy.
Shall we send you a message when we have discounts available?
Remind me later
Thank you! Please check your email inbox to confirm.
Products are supplied to verified businesses, institutions, and qualified professionals for research and development use only. Not for use in humans, animals, diagnosis, or therapy.
